Literature DB >> 10804169

The paired homeobox gene Uncx4.1 specifies pedicles, transverse processes and proximal ribs of the vertebral column.

M Leitges1, L Neidhardt, B Haenig, B G Herrmann, A Kispert.   

Abstract

The axial skeleton develops from the sclerotome, a mesenchymal cell mass derived from the ventral halves of the somites, segmentally repeated units located on either side of the neural tube. Cells from the medial part of the sclerotome form the axial perichondral tube, which gives rise to vertebral bodies and intervertebral discs; the lateral regions of the sclerotome will form the vertebral arches and ribs. Mesenchymal sclerotome cells condense and differentiate into chondrocytes to form a cartilaginous pre-skeleton that is later replaced by bone tissue. Uncx4.1 is a paired type homeodomain transcription factor expressed in a dynamic pattern in the somite and sclerotome. Here we show that mice homozygous for a targeted mutation of the Uncx4.1 gene die perinatally and exhibit severe malformations of the axial skeleton. Pedicles, transverse processes and proximal ribs, elements derived from the lateral sclerotome, are lacking along the entire length of the vertebral column. The mesenchymal anlagen for these elements are formed initially, but condensation and chondrogenesis do not occur. Hence, Uncx4.1 is required for the maintenance and differentiation of particular elements of the axial skeleton.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10804169     DOI: 10.1242/dev.127.11.2259

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  31 in total

Review 1.  The role of Bapx1 (Nkx3.2) in the development and evolution of the axial skeleton.

Authors:  L Lettice; J Hecksher-Sørensen; R Hill
Journal:  J Anat       Date:  2001 Jul-Aug       Impact factor: 2.610

2.  Acceleration of mouse mammary tumor virus-induced murine mammary tumorigenesis by a p53 172H transgene: influence of FVB background on tumor latency and identification of novel sites of proviral insertion.

Authors:  Gouri Chatterjee; Andrea Rosner; Yi Han; Edward T Zelazny; Baolin Li; Robert D Cardiff; Archibald S Perkins
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

3.  The T-box transcription factor Tbx18 maintains the separation of anterior and posterior somite compartments.

Authors:  Markus Bussen; Marianne Petry; Karin Schuster-Gossler; Michael Leitges; Achim Gossler; Andreas Kispert
Journal:  Genes Dev       Date:  2004-05-15       Impact factor: 11.361

4.  Deletion of the sclerotome-enriched lncRNA PEAT augments ribosomal protein expression.

Authors:  David A Stafford; Darwin S Dichmann; Jessica K Chang; Richard M Harland
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-16       Impact factor: 11.205

Review 5.  Patterning spinal nerves and vertebral bones.

Authors:  Roger Keynes
Journal:  J Anat       Date:  2017-10-24       Impact factor: 2.610

6.  Tgfbr2 regulates the maintenance of boundaries in the axial skeleton.

Authors:  Michael O Baffi; Molly A Moran; Rosa Serra
Journal:  Dev Biol       Date:  2006-06-07       Impact factor: 3.582

Review 7.  Division of labor during trunk neural crest development.

Authors:  Laura S Gammill; Julaine Roffers-Agarwal
Journal:  Dev Biol       Date:  2010-04-24       Impact factor: 3.582

8.  Dynamic CREB family activity drives segmentation and posterior polarity specification in mammalian somitogenesis.

Authors:  T Peter Lopez; Chen-Ming Fan
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-13       Impact factor: 11.205

9.  Neuropilin-mediated neural crest cell guidance is essential to organise sensory neurons into segmented dorsal root ganglia.

Authors:  Quenten Schwarz; Charlotte H Maden; Kathryn Davidson; Christiana Ruhrberg
Journal:  Development       Date:  2009-04-22       Impact factor: 6.868

10.  Neuropilin receptors guide distinct phases of sensory and motor neuronal segmentation.

Authors:  Julaine Roffers-Agarwal; Laura S Gammill
Journal:  Development       Date:  2009-04-29       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.